Translational Psychiatry

杂志介绍

Translational Psychiatry杂志介绍

《Translational Psychiatry》是一本以English为主的开放获取国际优秀期刊，中文名称转化精神病学，本刊主要出版、报道医学-PSYCHIATRY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为5.8，最新CiteScore 指数为11.5。

本刊近期中国学者发表的论文主要有：

• Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression

  Author: Guo, Bingqi; Zhang, Mengyao; Hao, Wensi; Wang, Yuping; Zhang, Tingting; Liu, Chunyan

• Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk

  Author: Zhang, TianHong; Zeng, JiaHui; Ye, JiaYi; Gao, YuQing; Hu, YeGang; Xu, LiHua; Wei, YanYan; Tang, XiaoChen; Liu, HaiChun; Chen, Tao; Li, ChunBo; Wan, ChunLing; Wang, JiJun

• Carboxypeptidase E conditional knockout mice exhibit learning and memory deficits and neurodegeneration

  Author: Fan, Fang-Cheng; Du, Yang; Zheng, Wen-Hui; Loh, Y. Peng; Cheng, Yong

• Physical exercise mediates a cortical FMRP-mTOR pathway to improve resilience against chronic stress in adolescent mice

  Author: Yan, Lan; Wang, Mei; Yang, Fengzhen; Wang, Yajie; Wang, Siqi; So, Kwok-Fai; Zhang, Li

英文介绍

Translational Psychiatry杂志英文介绍

Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.